Erbe, David V <br/><br/>
Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms.  [electronic resource] 

 -  Molecular pharmacology  Jan 2005 
 - 69-77 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0026-895X 
<br/><br/><label>Standard No.: </label>10.1124/mol.104.005553  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipocytes--cytology<br/>Animals<br/>Blood Glucose--drug effects<br/>Cell Differentiation--drug effects<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Hypolipidemic Agents--pharmacology<br/>Insulin--blood<br/>Kinetics<br/>Lipids--blood<br/>Male<br/>Mice<br/>Mice, Obese<br/>PPAR alpha--genetics<br/>PPAR gamma--genetics<br/>Phenylpropionates--pharmacology<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 1<br/>Protein Tyrosine Phosphatases--antagonists & inhibitors<br/>Recombinant Proteins--metabolism<br/>Thiophenes--pharmacology<br/>Triglycerides--blood